Pharmafile Logo
Pharmafocus logo
Advanced Search

Angle

Showing 5 posts of 5 posts found.

drug-trials

ANGLE unveils new strategy with executive reshuffle and name change to CelLBx Health

October 13, 2025
Business Services Angle

ANGLE has outlined a revised business strategy centred on tighter cost management, accelerated commercial execution, and long-term sustainability. The update …

News
Publishing image

ANGLE’s Parsortix system used in new cancer biology research

June 10, 2025
Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …

News

INDEPENDENT PARSORTIX STUDY HIGHLIGHTS BENEFITS OF COMBINED DNA ANALYSIS IN MELANOMA

August 1, 2024
Medical Communications, Research and Development Angle, Internal Medicine, Oncology, Parsortix, melanoma

Multi-analyte approach has potential to guide personalised cancer care CTC mutation profiles associated with more aggressive disease ANGLE plc. a …

News
Press release

ANGLE signs commercial agreement with AstraZeneca

April 26, 2024
Business Services Angle, AstraZeneca, Pharmacy, commercial agreement

ANGLE has announced that it has signed a supplier agreement with AstraZeneca for the development and validation of a methodology …

News
abbottweb

Abbott teams up with Angle for metastatic breast cancer study

February 6, 2018
Manufacturing and Production, Research and Development Abbott, Angle, Cancer, breast cancer, pharma

Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025